Monday, June 8, 2015

Top Rising Companies To Buy For 2015

A down European market and political upheaval and uncertainty in the United States has caused a considerable amount of hesitancy, if not downright fear, on Wall Street in 2013. Although performance was erratic for much of the year, the market has rallied in recent months with the year-to-date S&'s 500 Index rising to an all-time high.

But while the year has been filled with some of the biggest market swings in recent memory, many investors have enjoyed considerable gains so far, particularly during the last quarter. Following are some of the strongest performing stocks for 2013 that are well worth looking into in the coming year.

Celgene (NASDAQ: CELG)

Generally speaking, biotech stocks are usually among the strongest performers, so the inclusion of Celgene should not come as any real surprise. The company makes drug treatments for cancer and inflammatory disorders which are typically high-margin and thus very profitable.

Top 10 Heal Care Stocks To Own Right Now: Enzon Pharmaceuticals Inc. (ENZN)

Enzon Pharmaceuticals, Inc., a biotechnology company, engages in the research and development of therapeutics for cancer patients with unmet medical needs. The company?s drug-development programs utilize two platforms-Customized PEGylation Linker Technology and third-generation mRNA-targeting agents utilizing the Locked Nucleic Acid (LNA) technology. It currently holds four compounds in clinical development and multiple novel LNA targets in preclinical research. The company?s development product pipeline consists of PEG-SN38 compound that utilizes Customized Linker Technology, which is in Phase II clinical trials for the treatment of metastatic colorectal and breast cancer, as well as a Phase I trial for pediatric patients with cancer; and the Hypoxia-Inducible Factor-1 alpha antagonist in Phase I studies for the treatment of solid tumors and lymphoma. Its product line also comprises Survivin antagonist in Phase I study in pediatric patients with recurrent acute lymphoblas tic leukemia; Androgen Receptor antagonist, a validated target for the treatment of prostate cancer that is in a Phase I study in patients with castration-resistant prostate cancer; and rights to five compounds, including AR, HER3, beta-catenin, PI3KCA, and Gli2. Enzon Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Piscataway, New Jersey.

Advisors' Opinion:
  • [By Lisa Levin]

    Enzon Pharmaceuticals (NASDAQ: ENZN) shares tumbled 28.28% to reach a new 52-week low of $1.15. Enzon Pharmaceuticals shares have dropped 63.30% over the past 52 weeks, while the S&P 500 index has gained 28.75% in the same period.

  • [By Bryan Murphy]

    With just a quick glance at the company's recent news (or lack thereof), Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) doesn't look like anything all that special... or even trade-worthy. It only takes a brief look at the chart of ENZN, however, to conclude this stock - lack of new or not - has just become something trade-worthy, because the rest of the market has clearly started to fall back in love with it; there's no telling at what price the love affair could end.

  • [By Equities Lab]

    The stocks that currently pass the stock screen in order of market cap are Frontier Communications Corp , Crown Media Holdings (CRWN), Vonage Holding (VG), MCG Capital Corp (MCGC), 1-800-FLOWERS.COM (FLWS), MTR Gaming Corporation (MNTG), Alaska Communications (ALSK), and Enzon Pharmaceuticals (ENZN).

Top Rising Companies To Buy For 2015: CollabRx Inc (CLRX)

CollabRx, Inc., incorporated on September 20, 1995, is focused on developing and delivering content knowledge-based products and services that inform healthcare decision-making, with an emphasis on genomics-based precision medicine and big data analytics. The Company delivers content to users through Web-based applications and services in the cloud serving physicians and their patients in two settings: at the point-of-care in the clinic and indirectly, as a part of a genetic test report provided to an ordering physician by a diagnostic testing laboratory, (lab). The Company�� Therapy Finder Web-based application serves as an initial user-interface to the underlying knowledge base. It is available free of charge on its Website. In addition, a professional version is offered to registered physicians through MedPage Today, an offering of Everyday Health, Inc.

The Company�� offering provides the clinical interpretation of genetic variants present in human tumor biopsies, and is sold directly to diagnostic labs that perform molecular testing on patients. Its Genetic Variant Application (GVA) is compiled by its software platform to provide specific insights to a patient�� diagnostic test results on a test-by-test basis. The GVA results are provided to laboratories in a variety of forms, including with a front-end user Interface (UI) or directly integrated into a customer�� laboratory information management system (LIMS). The Company�� content is identified as Powered by CollabRx within the test report. Portions of its Web-based applications are available free to physicians and patients through commercial on-line media partners under a license and advertising or sponsorship revenue sharing arrangement. The content that, the Company offers to laboratories is sold based on a variation of Software as a service (SaaS) business model, in which its content is provided on a one-time, subscription or per test basis. It also receives fee-for-service payments in connection with customized user ! interfaces to its database.

Advisors' Opinion:
  • [By John Udovich]

    Small cap healthcare information stocks Everyday Health Inc (NYSE: EVDY), Foundation Medicine Inc (NASDAQ: FMI) and CollabRx Inc (NASDAQ: CLRX) help consumers and healthcare professionals deal with the increasing amount of information overload that comes with treating or figuring out how to treat patients.

  • [By James E. Brumley]

    If you were lucky enough to own WebMD Health Corp. (NASDAQ:WBMD) before the end of last week, then congratulations - you're up 20% today. And if you didn't get into WBMD before the close of business on Friday, well, it may be too late to step into it now (unless you like buying overextended stocks), but if you believe in the ongoing convergence of healthcare and digital information though - which is what put WebMD on the map - then you may want to take a closer look at CollabRx Inc. (NASDAQ:CLRX).

Top Rising Companies To Buy For 2015: HealthStream Inc (HSTM)

HealthStream, Inc. (HealthStream), incorporated in September 27, 1990, provides Internet-based learning and research solutions for healthcare organizations. The Company�� learning products are used by healthcare organizations to meet a range of their training, certification, and development needs, while its research products provide the customers information about patients��experiences, workforce engagement, physician relations, and community perceptions of their services. HealthStream�� products and services are organized into two segments: HealthStream Learning and HealthStream Research. HealthStream�� customers include healthcare organizations, pharmaceutical and medical device companies, and other participants in the healthcare industry. Its customer base across both learning and research business units includes over 3,000 healthcare organizations (predominately acute-care facilities) throughout all 50 states of the United States. In March 2014, the Company acquired Health Care Compliance Strategies, Inc., a Jericho, New York-based company focused on interactive and engaging online compliance training for healthcare organizations.

The Company�� core learning product is the HealthStream Learning Center (HLC), its learning platform provided through the Internet through software-as-a-service (SaaS) model. As of December 31, 2012, HealthStream had approximately 3.1 million contracted, primarily hospital-based subscribers, to the HLC platform. It delivers educational and training courseware to its customers through the HLC platform. Its research products and service offerings include satisfaction surveys, data analyses of survey results, and other research-based measurement tools focused on patients, physicians, employees, and members of the community. The Company�� core research product is the Patient Insights survey.

HealthStream Learning & Talent Management

Within HealthStream Learning & Talent Management, the Company brings training, assessment and! education content together with administrative and management tools through its HLC , HCC, and HPC. It also offers a more streamlined version of the HLC, HealthStream Express, along with HealthStream Connect, a content delivery platform that is designed for the singular purpose of allowing access to its content libraries. These content libraries allow HLC platform customers to subscribe to an array of additional courseware. Additionally, through its Hospital Direct capability in the HLC, medical device companies can offer online training support for their products and sponsor continuing education directly to healthcare workers.

The Company�� learning management system supports healthcare administrators in configuring training to meet the needs of various groups of employees, modifying training materials, and documenting training completion. It offer training, implementation, and account management services to facilitate adoption of its platform. Offered via a SaaS model, its Internet-based platform and its courseware are hosted in a central data center that allows authorized subscribers Internet access to its services.

In addition to the HLC, the Company offers an array of platform extensions, each serving a function for hospitals and health systems. The Authoring Center is a platform extension that provides healthcare organizations the capability to create Internet-based courses by moving their existing course material online or self-authoring new material and electively sharing these materials with its other customers through a courseware exchange. It also offers Authoring Pro, an upgraded product, which includes a licensed image library, as an additional subscription to this product. The HealthStream Competency Center (HCC) is its SaaS-based platform extension for competency management solution for healthcare organizations, provides customers tools to assess competency and appraise performance.

SimCenter, the Company�� platform extension offer products and ! services ! focused on accelerating the global adoption of simulation-based learning by healthcare providers with a focus on improving clinical competencies and patient outcomes. The new venture offers healthcare organizations and medical and nursing schools worldwide a range of integrated SaaS applications that accelerate development and distribution of simulation content; enable enterprise-wide management of simulation centers, simulators, and programs, and support assessment of the effectiveness of simulation training as part of complete curricula.

The HealthStream Improvement Center is a SaaS-based platform extension related to its research offering. This extension is an online system for hospital leaders to optimize and accelerate the execution of improvement plans, including those based on results from its patient, employee, physician, and community surveys. The Improvement Center, a licensed technology, is one of a number of solutions from HealthStream Research that include a line of survey products, national benchmarks, HCAHPS Improvement Library, consulting services, and other support tools.

HealthStream Research

HealthStream Research complements HealthStream Learning�� product and service offerings by providing hospital-based customers with Patient Insights, Employee Insights, Physician Insights, and Community Insights surveys, data analyses of survey results, and other research-based measurement tools. Its services are designed to provide thorough analyses that provide insightful recommendations for change; benchmarking capability using its databases, and consulting services to identify solutions for its customers based on their survey results. Its survey and research solutions focus on providing valid data to assist its customers. In addition to collecting and reporting data, the Company provides analysis and consulting to help customers understand their survey results and the underlying impact on their business. It is with this insight that healthcare organizati! ons are a! ble to develop plans for improved performance that can be delivered through its learning solutions.

The Company competes with Cornerstone OnDemand, Healthcare Source, Oracle, SABA, SAP, SumTotal Systems, Avatar International, Gallup, National Research Corporation, Press Ganey Associates, Professional Research Consultants, Inc., Kenexa, Foresight, B-Line Medical, CAE/Meti, and EMS

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Healthstream (NASDAQ: HSTM) was down, falling 4.28 percent to $25.94 after Northland Securities downgraded the stock from Outperform to Market Perform and lowered the target price from $43 to $30.

Top Rising Companies To Buy For 2015: Powershares Dynamic Retail Portfolio (PMR)

PowerShares Dynamic Retail Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the Dynamic Retail Intellidex Index (the Retail Intellidex). The Retail Intellidex consists of stocks of 30 United States retailers. These are companies that are principally engaged in operating general merchandise stores, such as department stores, discount stores, warehouse clubs and superstores; specialty stores, including apparel, electronics, accessories and footwear stores;, and home improvement and home furnishings stores. Dealers of motor vehicles and parts, auction houses or rental companies may also be included. Stocks are selected principally on the basis of their capital appreciation potential as identified by the AMEX (the Intellidex Provider) pursuant to its Intellidex methodology. The Fund�� investment advisor is PowerShares Capital Management LLC.

The Fund will normally invest at least 80% of its total assets in common stocks of retail companies. It will normally invest at least 90% of its total assets in common stocks that comprise the Retail

Intellidex. The Fund, using an indexing investment approach, attempts to replicate the performance of the Retail Intellidex. The Fund generally will invest in all of the stocks comprising the Retail Intellidex in proportion to their weightings in the Retail Intellidex.

Advisors' Opinion:
  • [By John Udovich]

    TheEconomicCollapseBlog.com has a shocking�post entitled, ��0 Facts About The Great U.S. Retail Apocalypse That Will Blow Your Mind,��which might make you want to consider shorting or reevaluating any investment strategies involving retail or retail ETFs like the SPDR S&P Retail ETF (NYSEARCA: XRT), PowerShares Dynamic Retail ETF (NYSEARCA: PMR), Market Vectors Retail ETF (NYSEARCA: RTH) and Direxion Daily Retail Bull 3X Shares (NYSEARCA: RETL).�Before you dismiss something from a blog with the words ��conomic Collapse��in it (they are, after all, peddling ��oom and gloom�� because the Obama administration plus Joe Biden�and their surrogates in the media keep telling you there is an economic recovery along with growth in jobs, consider just the following retail store closure plans or job cuts mentioned in the post:

  • [By John Udovich]

    Small cap Checkpoint Systems, Inc (NYSE: CKP) fights shoplifting or retail theft and other forms of�"shrink��that costs retailers over $112 billion worldwide last year (according to a study funded by the company), meaning it might be an interesting stock to take a closer look at and to compare its performance with that of SPDR S&P Retail ETF (NYSEARCA: XRT) and PowerShares Dynamic Retail ETF (NYSEARCA: PMR). Just how bad can shoplifting or shrink be for a retailer? Troubled retailer J.C. Penney Company, Inc (NYSE: JCP) has just reported that shoplifting took a full percentage point off the department store chain's profit margins during the quarter. Moreover and given that tens of millions of Americans are now facing higher health insurance costs thanks to Obamacare (which will likely impact consumer discretionary spending),�retailers�will need to find ways to shore up their margins and bottom lines by preventing�retail theft with solutions from company�� like Checkpoint Systems.

  • [By Ron Rowland]

    The five funds consist of three ETFs and two traditional mutual funds. The names and gains of the three ETFs were PowerShares Dynamic Retailing ETF (PMR) 0.6%, Market Vectors Retail ETF (RTH) 0.7%, and SPDR S&P Retail ETF (XRT) 1.1%.

No comments:

Post a Comment